Effects of Angiotensin-Receptor Blockade With Olmesartan on Carotid Atherosclerosis in Patients With Hypertension: The Confirmatory Olmesartan Plaque Regression Study.

Trial Profile

Effects of Angiotensin-Receptor Blockade With Olmesartan on Carotid Atherosclerosis in Patients With Hypertension: The Confirmatory Olmesartan Plaque Regression Study.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2013

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Atenolol
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Acronyms CONFIRM
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 30 Mar 2012 Actual patient number is 114 according to ClinicalTrials.gov.
    • 22 Feb 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 22 Feb 2012 Planned end date changed from 1 Jun 2012 to 1 Dec 2012 as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top